These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 33036546)

  • 1. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection.
    Robinson FA; Mihealsick RP; Wagener BM; Hanna P; Poston MD; Efimov IR; Shivkumar K; Hoover DB
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1059-H1068. PubMed ID: 33036546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19, ACE2, and the cardiovascular consequences.
    South AM; Diz DI; Chappell MC
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
    Young MJ; Clyne CD; Chapman KE
    J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
    Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED
    Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.
    Lores E; Wysocki J; Batlle D
    Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
    Hooper NM; Lambert DW; Turner AJ
    Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?
    Yan T; Xiao R; Lin G
    FASEB J; 2020 May; 34(5):6017-6026. PubMed ID: 32306452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
    Cano F; Gajardo M; Freundlich M
    Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
    Roshanravan N; Ghaffari S; Hedayati M
    Diabetes Metab Syndr; 2020; 14(4):637-639. PubMed ID: 32428864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.
    Barillà F; Bassareo PP; Calcaterra G; Romeo F; Mehta JL
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):630-633. PubMed ID: 32740495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
    Groß S; Jahn C; Cushman S; Bär C; Thum T
    J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.
    Banu N; Panikar SS; Leal LR; Leal AR
    Life Sci; 2020 Sep; 256():117905. PubMed ID: 32504757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.
    Sinha S; Sehgal A; Sehgal R
    Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.